Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
1.73 0.04(2.37%) Apr 17, 4:00PM EDT
|Pre-Market : 1.74 Up 0.01 (0.58%) 8:42AM EDT - Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJan 31, 2014Oct 31, 2013Jul 31, 2013Apr 30, 2013
Total Revenue 3,885   7,354   4,688   4,254  
Cost of Revenue2,416  4,195  2,670  3,217  
Gross Profit 1,469   3,159   2,018   1,037  
Operating Expenses
Research Development6,649  6,957  5,304  5,835  
Selling General and Administrative4,563  4,016  4,334  3,665  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (9,743) (7,814) (7,620) (8,463)
Income from Continuing Operations
Total Other Income/Expenses Net23  24  21  15  
Earnings Before Interest And Taxes(9,720)(7,790)(7,599)(8,448)
Interest Expense4   -  1  1  
Income Before Tax(9,724)(7,790)(7,600)(8,449)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(9,724)(7,790)(7,600)(8,449)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (9,724) (7,790) (7,600) (8,449)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (9,724) (7,790) (7,600) (8,449)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.